Four months after raising funds from Hoxton Ventures and dRX Capital, a branch of Novartis Pharma AG, Peptone , a computational molecular physics company specializing in drug discovery and engineering tools for proteins, installed an NVIDIA DGX A100 system in Verne Global’s HPC-optimized data center in Keflavik, Iceland. The company also announced a collaboration with NVIDIA to evolve its AI-based protein engineering system to meet growing market demand for therapeutic proteins.
Peptone Ltd. completes the installation of their first NVIDIA DGX A100 supercomputing node in Verne Global HPC-facility in Keflavik Iceland to scale up their AI-driven Protein Engineering Operating System (PeOS). Peptone Ltd. becomes one of the first computational biology and molecular physics companies in Europe to operate on 100% renewable energy sources.
Peptone’s team of physicists, structural biologists, computer scientists and mathematicians, led by physicist and founder, Dr. Kamil Tamiola, have spent the past three years developing the basics of the operating system of protein engineering (PeOS). In collaboration with NVIDIA, Peptone developed PeOS to handle highly parallel molecular simulations that are orchestrated and controlled by reinforcement learning algorithms. The main function of the platform is an automated search for non-obvious protein variants with interesting therapeutic properties that can be cost effectively manufactured.
Peptone chose to host its new NVIDIA DGX A100 supercomputer on the Verne Global campus because it is powered by 100 percent renewable energy and, as part of the NVIDIA DGX-Ready data center program, it is optimized to maintain and Support high density HPC applications running within NVIDIA infrastructures.
Dr Kamil Tamiola, CEO and Founder of Peptone, said: “The therapeutic protein business is a huge industry and with our growth and the development of our supercomputing capability, we can make significant strides to deliver faster coveted protein-based treatments on the market. Our collaboration with NVIDIA gives us access to the best hardware and support for AI and supercomputers. The decision to install our IT hardware at the Verne International Center in Keflavik comes from our commitment to sustainability and security, as no other Tier 3 facility in this part of the world offers this level of resilience. operational and none of them works with fully renewable energy. We are proud to be one of the first startups to have their own supercomputer hardware running on fully renewable energy sources. ”
“GPUs accelerate every phase of drug discovery, and in the early stages of drug development, they can dramatically reduce time to market,” said Craig Rhodes , EMEA Head of Healthcare and Life Sciences at NVIDIA for artificial intelligence. “As a member of NVIDIA Inception , our acceleration platform for AI startups, Peptone is demonstrating remarkable success in using its technology to advance this area of discovery. ”
“We are delighted that Peptone has chosen Verne Global as a partner for its centers at a critical juncture for the company,” said Dominic Ward, CEO of Verne Global. “Our facility, powered by 100 percent renewable geothermal and hydroelectric power sources, is optimized for the secure and scalable high-intensity computing required by Peptone to successfully meet the growing demands of the therapeutic protein market and accelerate time-to-market. protein-based drugs market. “
